301156 美农生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.2006.4237.9779.49424.423
总资产报酬率 ROA (%)1.1406.0877.3077.41216.102
投入资产回报率 ROIC (%)1.1986.4137.8988.41619.665

边际利润分析
销售毛利率 (%)28.15828.81629.93129.03529.574
营业利润率 (%)9.66411.12813.22412.11014.499
息税前利润/营业总收入 (%)8.94710.35812.97010.80715.019
净利润/营业总收入 (%)8.89610.12012.49910.86112.917

收益指标分析
经营活动净收益/利润总额(%)81.90794.34882.535104.27988.650
价值变动净收益/利润总额(%)2.2333.0515.839-1.2304.080
营业外收支净额/利润总额(%)1.4882.2945.004-0.4190.406

偿债能力分析
流动比率 (X)15.08811.38414.7845.9592.180
速动比率 (X)12.8799.80212.7345.3431.671
资产负债率 (%)4.2875.7484.73511.85538.804
带息债务/全部投入资本 (%)-0.067-0.3020.0041.51727.961
股东权益/带息债务 (%)-148,644.161-33,123.0412,243,683.7556,478.289256.495
股东权益/负债合计 (%)2,232.6561,639.8752,011.918743.514157.703
利息保障倍数 (X)-10.362-10.049-13.639-8.63032.598

营运能力分析
应收账款周转天数 (天)79.56866.97168.22573.18255.438
存货周转天数 (天)84.26274.93872.04970.15660.826